Global Drugs for Malaria Market Research Report 2020

Global Drugs for Malaria Market Research Report 2020

Table of Contents
1 Drugs for Malaria Market Overview
1.1 Product Overview and Scope of Drugs for Malaria
1.2 Drugs for Malaria Segment by Type
1.2.1 Global Drugs for Malaria Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Drugs for Malaria Segment by Application
1.3.1 Drugs for Malaria Sales Comparison by Application: 2020 VS 2026
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Global Drugs for Malaria Market Size Estimates and Forecasts
1.4.1 Global Drugs for Malaria Revenue 2015-2026
1.4.2 Global Drugs for Malaria Sales 2015-2026
1.4.3 Drugs for Malaria Market Size by Region: 2020 Versus 2026
2 Global Drugs for Malaria Market Competition by Manufacturers
2.1 Global Drugs for Malaria Sales Market Share by Manufacturers (2015-2020)
2.2 Global Drugs for Malaria Revenue Share by Manufacturers (2015-2020)
2.3 Global Drugs for Malaria Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Drugs for Malaria Manufacturing Sites, Area Served, Product Type
2.5 Drugs for Malaria Market Competitive Situation and Trends
2.5.1 Drugs for Malaria Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Drugs for Malaria Players (Opinion Leaders)
3 Drugs for Malaria Retrospective Market Scenario by Region
3.1 Global Drugs for Malaria Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Drugs for Malaria Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Drugs for Malaria Market Facts & Figures by Country
3.3.1 North America Drugs for Malaria Sales by Country
3.3.2 North America Drugs for Malaria Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drugs for Malaria Market Facts & Figures by Country
3.4.1 Europe Drugs for Malaria Sales by Country
3.4.2 Europe Drugs for Malaria Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drugs for Malaria Market Facts & Figures by Region
3.5.1 Asia Pacific Drugs for Malaria Sales by Region
3.5.2 Asia Pacific Drugs for Malaria Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drugs for Malaria Market Facts & Figures by Country
3.6.1 Latin America Drugs for Malaria Sales by Country
3.6.2 Latin America Drugs for Malaria Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Drugs for Malaria Market Facts & Figures by Country
3.7.1 Middle East and Africa Drugs for Malaria Sales by Country
3.7.2 Middle East and Africa Drugs for Malaria Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drugs for Malaria Historic Market Analysis by Type
4.1 Global Drugs for Malaria Sales Market Share by Type (2015-2020)
4.2 Global Drugs for Malaria Revenue Market Share by Type (2015-2020)
4.3 Global Drugs for Malaria Price Market Share by Type (2015-2020)
4.4 Global Drugs for Malaria Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Drugs for Malaria Historic Market Analysis by Application
5.1 Global Drugs for Malaria Sales Market Share by Application (2015-2020)
5.2 Global Drugs for Malaria Revenue Market Share by Application (2015-2020)
5.3 Global Drugs for Malaria Price by Application (2015-2020)
6 Company Profiles and Key Figures in Drugs for Malaria Business
6.1 Cipla
6.1.1 Corporation Information
6.1.2 Cipla Description, Business Overview and Total Revenue
6.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Cipla Products Offered
6.1.5 Cipla Recent Development
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Drugs for Malaria Production Sites and Area Served
6.2.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
6.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Guilin Pharmaceutical Products Offered
6.2.5 Guilin Pharmaceutical Recent Development
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Drugs for Malaria Production Sites and Area Served
6.3.2 IPCA Laboratories Description, Business Overview and Total Revenue
6.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.3.4 IPCA Laboratories Products Offered
6.3.5 IPCA Laboratories Recent Development
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Drugs for Malaria Production Sites and Area Served
6.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GlaxoSmithKline Products Offered
6.4.5 GlaxoSmithKline Recent Development
6.5 Mylan Labs
6.5.1 Mylan Labs Drugs for Malaria Production Sites and Area Served
6.5.2 Mylan Labs Description, Business Overview and Total Revenue
6.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Mylan Labs Products Offered
6.5.5 Mylan Labs Recent Development
6.6 Roche
6.6.1 Roche Drugs for Malaria Production Sites and Area Served
6.6.2 Roche Description, Business Overview and Total Revenue
6.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Roche Products Offered
6.6.5 Roche Recent Development
6.7 Novartis
6.6.1 Novartis Drugs for Malaria Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.7.5 Novartis Recent Development
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Drugs for Malaria Production Sites and Area Served
6.8.2 Sanofi Aventis Description, Business Overview and Total Revenue
6.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanofi Aventis Products Offered
6.8.5 Sanofi Aventis Recent Development
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Drugs for Malaria Production Sites and Area Served
6.9.2 Ajanta Pharma Description, Business Overview and Total Revenue
6.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Ajanta Pharma Products Offered
6.9.5 Ajanta Pharma Recent Development
7 Drugs for Malaria Manufacturing Cost Analysis
7.1 Drugs for Malaria Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drugs for Malaria
7.4 Drugs for Malaria Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drugs for Malaria Distributors List
8.3 Drugs for Malaria Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Drugs for Malaria Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drugs for Malaria by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Drugs for Malaria by Type (2021-2026)
10.2 Drugs for Malaria Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drugs for Malaria by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Drugs for Malaria by Application (2021-2026)
10.3 Drugs for Malaria Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drugs for Malaria by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Drugs for Malaria by Region (2021-2026)
10.4 North America Drugs for Malaria Estimates and Projections (2021-2026)
10.5 Europe Drugs for Malaria Estimates and Projections (2021-2026)
10.6 Asia Pacific Drugs for Malaria Estimates and Projections (2021-2026)
10.7 Latin America Drugs for Malaria Estimates and Projections (2021-2026)
10.8 Middle East and Africa Drugs for Malaria Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drugs for Malaria Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Drugs for Malaria Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Drugs for Malaria Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Drugs for Malaria Manufacturers Covered in This Study
Table 5. Global Drugs for Malaria Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Drugs for Malaria Sales Share by Manufacturers (2015-2020)
Table 7. Global Drugs for Malaria Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Drugs for Malaria Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Drugs for Malaria Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Drugs for Malaria Sales Sites and Area Served
Table 11. Manufacturers Drugs for Malaria Product Types
Table 12. Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Drugs for Malaria Players
Table 16. Global Drugs for Malaria Sales (K Units) by Region (2015-2020)
Table 17. Global Drugs for Malaria Sales Market Share by Region (2015-2020)
Table 18. Global Drugs for Malaria Revenue (Million US$) by Region (2015-2020)
Table 19. Global Drugs for Malaria Revenue Market Share by Region (2015-2020)
Table 20. North America Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 21. North America Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 22. North America Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 24. Europe Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 25. Europe Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 26. Europe Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Drugs for Malaria Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Drugs for Malaria Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Drugs for Malaria Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Drugs for Malaria Revenue Market Share by Region (2015-2020)
Table 32. Latin America Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 33. Latin America Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 34. Latin America Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 40. Global Drugs for Malaria Sales (K Units) by Type (2015-2020)
Table 41. Global Drugs for Malaria Sales Share by Type (2015-2020)
Table 42. Global Drugs for Malaria Revenue (Million US$) by Type (2015-2020)
Table 43. Global Drugs for Malaria Revenue Share by Type (2015-2020)
Table 44. Global Drugs for Malaria Price (USD/Unit) by Type (2015-2020)
Table 45. Global Drugs for Malaria Sales (K Units) by Application (2015-2020)
Table 46. Global Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 47. Global Drugs for Malaria Sales Growth Rate by Application (2015-2020)
Table 48. Cipla Drugs for Malaria Corporation Information
Table 49. Cipla Description and Business Overview
Table 50. Cipla Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Cipla Main Product
Table 52. Cipla Recent Development
Table 53. Guilin Pharmaceutical Drugs for Malaria Corporation Information
Table 54. Guilin Pharmaceutical Corporation Information
Table 55. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Guilin Pharmaceutical Main Product
Table 57. Guilin Pharmaceutical Recent Development
Table 58. IPCA Laboratories Drugs for Malaria Corporation Information
Table 59. IPCA Laboratories Corporation Information
Table 60. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. IPCA Laboratories Main Product
Table 62. IPCA Laboratories Recent Development
Table 63. GlaxoSmithKline Drugs for Malaria Corporation Information
Table 64. GlaxoSmithKline Corporation Information
Table 65. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. GlaxoSmithKline Main Product
Table 67. GlaxoSmithKline Recent Development
Table 68. Mylan Labs Drugs for Malaria Corporation Information
Table 69. Mylan Labs Corporation Information
Table 70. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Mylan Labs Main Product
Table 72. Mylan Labs Recent Development
Table 73. Roche Drugs for Malaria Corporation Information
Table 74. Roche Corporation Information
Table 75. Roche Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Roche Main Product
Table 77. Roche Recent Development
Table 78. Novartis Drugs for Malaria Corporation Information
Table 79. Novartis Corporation Information
Table 80. Novartis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Main Product
Table 82. Novartis Recent Development
Table 83. Sanofi Aventis Drugs for Malaria Corporation Information
Table 84. Sanofi Aventis Corporation Information
Table 85. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Sanofi Aventis Main Product
Table 87. Sanofi Aventis Recent Development
Table 88. Ajanta Pharma Drugs for Malaria Corporation Information
Table 89. Ajanta Pharma Corporation Information
Table 90. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Ajanta Pharma Main Product
Table 92. Ajanta Pharma Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Drugs for Malaria Distributors List
Table 96. Drugs for Malaria Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Drugs for Malaria Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Drugs for Malaria Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Drugs for Malaria Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Drugs for Malaria Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Drugs for Malaria Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Drugs for Malaria Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Drugs for Malaria Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Drugs for Malaria Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Drugs for Malaria Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Drugs for Malaria Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Drugs for Malaria
Figure 2. Global Drugs for Malaria Sales Market Share by Type: 2020 VS 2026
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Drugs for Malaria Consumption Market Share by Application: 2020 VS 2026
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Other
Figure 10. Global Drugs for Malaria Market Size 2015-2026 (US$ Million)
Figure 11. Global Drugs for Malaria Sales Capacity (K Units) (2015-2026)
Figure 12. Global Drugs for Malaria Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Drugs for Malaria Sales Share by Manufacturers in 2020
Figure 14. Global Drugs for Malaria Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Drugs for Malaria Revenue in 2019
Figure 16. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Drugs for Malaria Sales Market Share by Region (2015-2020)
Figure 18. Global Drugs for Malaria Sales Market Share by Region in 2019
Figure 19. Global Drugs for Malaria Revenue Market Share by Region (2015-2020)
Figure 20. Global Drugs for Malaria Revenue Market Share by Region in 2019
Figure 21. North America Drugs for Malaria Sales Market Share by Country in 2019
Figure 22. North America Drugs for Malaria Revenue Market Share by Country in 2019
Figure 23. U.S. Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Drugs for Malaria Sales Market Share by Country in 2019
Figure 28. Europe Drugs for Malaria Revenue Market Share by Country in 2019
Figure 29. Germany Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Drugs for Malaria Sales Market Share by Region in 2019
Figure 40. Asia Pacific Drugs for Malaria Revenue Market Share by Region in 2019
Figure 41. China Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Drugs for Malaria Sales Market Share by Country in 2019
Figure 64. Latin America Drugs for Malaria Revenue Market Share by Country in 2019
Figure 65. Mexico Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Drugs for Malaria Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Drugs for Malaria Revenue Market Share by Country in 2019
Figure 73. Turkey Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Drugs for Malaria by Type (2015-2020)
Figure 80. Sales Market Share of Drugs for Malaria by Type in 2019
Figure 81. Revenue Share of Drugs for Malaria by Type (2015-2020)
Figure 82. Revenue Market Share of Drugs for Malaria by Type in 2019
Figure 83. Global Drugs for Malaria Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Drugs for Malaria Sales Market Share by Application (2015-2020)
Figure 85. Global Drugs for Malaria Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Drugs for Malaria by Application (2015-2020)
Figure 87. Global Revenue Share of Drugs for Malaria by Application in 2020
Figure 88. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. IPCA Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Mylan Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Ajanta Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Drugs for Malaria
Figure 99. Manufacturing Process Analysis of Drugs for Malaria
Figure 100. Drugs for Malaria Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Drugs for Malaria Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Drugs for Malaria Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Drugs for Malaria Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Drugs for Malaria Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Drugs for Malaria Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs